Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

Cannabis Spin-Off Eases Nerve Pain in Rats

Will Boggs, MD

Reuters

Monday 11 Aug 2003

---

NEW YORK (Reuters Health) - A cannabis-like drug currently undergoing lab
tests may hold out relief for people with painful nerve damage in their
arms or legs, without causing the "high" that comes with smoking pot.

The effects of cannabis and related compounds come from the interaction of
the drug with so-called receptors, which are of different types within the
brain and central nervous system as opposed to outside the brain in other
areas of the body.

The CB1 receptors in the brain cause the mental effects of the drug, while
the "peripheral" CB2 receptors are responsible for the benefits that some
patients with glaucoma or cancer, for example, get from cannabis.

Now scientists have developed a drug that acts mainly on the CB2 receptors.

"By targeting a specific class of cannabinoid receptors, we have developed
selective cannabinoid drugs (drugs with actions similar to those of THC,
the active ingredient in marijuana) that should lack the undesirable
central nervous system side effects (such as sedation and anxiety) and the
abuse potential of non-selective cannabinoid drugs," Dr. T. Philip Malan
Jr. told Reuters Health.

Malan, from the University of Arizona in Tucson, and associates tested the
drug, known as AM1241, in lab rats that develop an exaggerated sensitivity
to heat and touch, mimicking neuropathic pain.

They found that increasing doses of the drug increasingly blocked the
animals' responses to touch and heat. These beneficial effects of AM1241
were completely reversed when the animals were given a drug that blocked
CB2 receptors, but not one that blocked CB1 receptors, the researchers
report in the Proceedings of the National Academy of Sciences.

Drugs like AM1241 that activate CB2 receptors have been shown to reduce
various types of pain, Malan explained. "We have emphasized their actions
in neuropathic pain because there is a strong need for new therapies for
neuropathic pain."

Despite the promise, he did sound a note of caution. CB2 receptors are
found on immune cells, "and drugs acting on CB2 receptors can inhibit
immune cell function." He doesn't think this will cause harmful immune
suppression, because other drugs with similar effects do not, but it still
needs to be looked at.

SOURCE: Proceedings of the National Academy of Sciences of the USA, August
11, 2003, online Early Edition.

 

 

 

After you have finished reading this article you can click here to go back.




This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!